Skip to main content
. 2023 Oct 6;10:1280714. doi: 10.3389/fmed.2023.1280714

Table 5.

Comparison of parameters between pre-IVI and post-IVI.

WR IR OR
Pre-IVI, n = 11 Post-IVI, n = 11 P Pre-IVI, n = 11 Post-IVI, n = 11 P Pre-IVI, n = 11 Post-IVI, n = 11 P
QNS 60 (26–101) 64 (24–84) 0.247 14 (9–36) 15 (9–20) 0.241 43 (21–94) 48 (15–63) 0.533
QHD 239 (76–411) 210 (71–232) 0.003 33 (20–75) 23 (12–49) 0.173 216 (59–318) 168 (55–209) 0.006
QHC 20 (8–37) 27 (13–40) 0.213 0 (0–1) 0 (0–1) 0.317 19 (8–37) 27 (12–38) 0.213
VNS 2.88 × 105 (1.14 × 105–3.68 × 105) 2.47 × 105 (1.05 × 105–3.54 × 105) 0.033 5.32 × 104 (3.40 × 104–1.35 × 105) 5.27 × 104 (3.85 × 104–9.58 × 104) 0.374 2.16 × 105 (9.22 × 104–3.45 × 105) 1.94 × 105 (6.43 × 104–2.57 × 105) 0.047
VHD 9.22 × 106 (2.56 × 106–1.30 × 107) 5.66 × 106 (2.55 × 106–8.45 × 106) 0.003 9.71 × 105 (5.74 × 105–2.04 × 106) 7.61 × 105 (2.86 × 105–1.32 × 106) 0.155 7.67 × 106 (1.84 × 106–1.05 × 107) 4.52 × 106 (2.10 × 106–7.69 × 106) 0.006
VHC 1.18 × 107 (1.53 × 106–2.85 × 107) 9.97 × 106 (4.65 × 106–2.66 × 107) 0.929 0 (0–1.53 × 105) 0 (0–2.11 × 105) 0.345 1.18 × 107 (1.53 × 106–2.84 × 107) 9.97 × 106 (4.65 × 106–2.66 × 107) 0.929
DNS,fovea 991.35 (959.52–1072.49) 1042.95 (1014.85–1064.91) 0.534 1103.94 (1057.83–1212.58) 1086.73 (1030.12–1237.50) 0.534 954.27 (906.40–1023.99) 1011.02 (960.74–1060.23) 0.594
DHD,fovea 980.67 (921.75–1028.42) 1005.93 (973.22–1066.87) 0.131 1035.34 (919.43–1184.14) 1014.14 (956.53–1106.73) 0.79 1000.76 (888.70–1024.25) 1011.21 (948.34–1083.34) 0.131
DHC,fovea 985.87 (909.17–1093.25) 970.50 (833.29–1020.72) 0.79 0 (0–909.00) 0 (0–664.33) 0.893 9983.01 (909.17–1093.25) 970.50 (833.29–1022.10) 0.79
DNS,RPE 216.45 (204.38–239.87) 190.71 (160.61–202.84) 0.026 293.66 (260.66–322.31) 234.73 (197.79–246.13) 0.013 191.16 (179.96–214.40) 174.93 (147.46–185.65) 0.075
DHD,RPE 213.52 (188.28–230.87) 177.60 (162.27–200.99) 0.008 278.50 (270.14–336.15) 242.80 (210.56–249.98) 0.016 196.62 (181.72–211.72) 172.52 (149.30–192.06) 0.004
DHC,RPE 213.86 (202.93–273.82) 177.44 (167.83–204.70) 0.004 0 (0–274.30) 0 (0–242.46) 0.686 213.28 (202.93–273.82) 177.44 (167.83–204.70) 0.004
CMT 401 (383–490) 315 (253–367) 0.003

1the variable was expressed as the median (IQR); the P value was obtained by Wilcoxon Signed Rank Test. 2WR, the whole retinal layer; IR, the inner retinal layer; OR, the outer retinal layer; IVI, intravitreal injection; QNS, noise signal quantity; QHD, hyperreflective dots quantity; QHC, hyperreflective clump quantity; VNS, noise signal volume; VHD, hyperreflective dots volume; VHC, hyperreflective clump volume; DNS,fovea, distance between noise signal and fovea; DHD,fovea, distance between hyperreflective dots and fovea; DHC,fovea, distance between hyperreflective clumps and fovea; DNS,RPE, distance between noise signal and RPE; DHD,RPE, distance between hyperreflective dots and RPE; DHC,RPE, distance between hyperreflective clumps and RPE; CMT, central macular thickness.